PG-102(MG12)

MG12 · ProGen. Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PG-102(MG12), covering 2025-05-06 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes [Phase 2]